Ramsay Générale de Santé SA (GDS.PA)
EUR 9.66
(-0.21%)
EUR 9.66
(-0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 184.2 Million EUR | -15.58% |
| 2022 | 218.2 Million EUR | -22.38% |
| 2021 | 281.1 Million EUR | 3.35% |
| 2020 | 272 Million EUR | 47.27% |
| 2019 | 184.7 Million EUR | 17.72% |
| 2018 | 156.9 Million EUR | 24.82% |
| 2017 | 125.7 Million EUR | -5.13% |
| 2016 | 132.5 Million EUR | -4.68% |
| 2015 | 139 Million EUR | 44.64% |
| 2014 | 96.1 Million EUR | -7.95% |
| 2013 | 104.4 Million EUR | -9.38% |
| 2012 | 115.2 Million EUR | 129.03% |
| 2011 | 50.3 Million EUR | -51.59% |
| 2010 | 103.9 Million EUR | -20.93% |
| 2009 | 131.4 Million EUR | -18.08% |
| 2008 | 160.4 Million EUR | 50.19% |
| 2007 | 106.8 Million EUR | -65.89% |
| 2006 | 313.1 Million EUR | 238.85% |
| 2005 | 92.4 Million EUR | 28.69% |
| 2004 | 71.8 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | 46.5 Million EUR | -55.71% |
| 2023 Q3 | 56.1 Million EUR | -28.26% |
| 2023 FY | 184.2 Million EUR | -15.58% |
| 2023 Q4 | 18.6 Million EUR | -66.84% |
| 2023 Q2 | 78.2 Million EUR | 68.17% |
| 2022 Q2 | 113.1 Million EUR | 101.25% |
| 2022 FY | 218.2 Million EUR | -22.38% |
| 2022 Q4 | 105 Million EUR | 59.09% |
| 2022 Q3 | 66 Million EUR | -41.64% |
| 2022 Q1 | 56.2 Million EUR | -57.42% |
| 2021 Q4 | 132 Million EUR | 23.25% |
| 2021 FY | 281.1 Million EUR | 3.35% |
| 2021 Q1 | 78.35 Million EUR | -45.93% |
| 2021 Q2 | 149.1 Million EUR | 90.3% |
| 2021 Q3 | 107.1 Million EUR | -28.17% |
| 2020 Q4 | 144.9 Million EUR | 154.88% |
| 2020 FY | 272 Million EUR | 47.27% |
| 2020 Q3 | 56.85 Million EUR | -55.27% |
| 2020 Q2 | 127.1 Million EUR | 60.58% |
| 2020 Q1 | 79.15 Million EUR | 269.86% |
| 2019 Q1 | 47.05 Million EUR | -56.44% |
| 2019 Q2 | 94.1 Million EUR | 100.0% |
| 2019 Q3 | 45.3 Million EUR | -51.86% |
| 2019 Q4 | 21.4 Million EUR | -52.76% |
| 2019 FY | 184.7 Million EUR | 17.72% |
| 2018 FY | 156.9 Million EUR | 24.82% |
| 2018 Q4 | 108 Million EUR | 99.81% |
| 2018 Q3 | 54.05 Million EUR | 121.52% |
| 2018 Q2 | 24.4 Million EUR | 0.0% |
| 2018 Q1 | 24.4 Million EUR | -44.55% |
| 2017 Q4 | 44 Million EUR | 0.0% |
| 2017 Q3 | 44 Million EUR | 133.42% |
| 2017 Q1 | 18.85 Million EUR | -54.19% |
| 2017 Q2 | 18.85 Million EUR | 0.0% |
| 2017 FY | 125.7 Million EUR | -5.13% |
| 2016 Q3 | 41.15 Million EUR | 63.94% |
| 2016 Q2 | 25.1 Million EUR | 0.0% |
| 2016 FY | 132.5 Million EUR | -4.68% |
| 2016 Q1 | 25.1 Million EUR | -43.97% |
| 2016 Q4 | 41.15 Million EUR | 0.0% |
| 2015 Q1 | 24.7 Million EUR | 0.0% |
| 2015 FY | 139 Million EUR | 44.64% |
| 2015 Q2 | 24.7 Million EUR | 0.0% |
| 2015 Q3 | 44.8 Million EUR | 81.38% |
| 2015 Q4 | 44.8 Million EUR | 0.0% |
| 2014 FY | 96.1 Million EUR | -7.95% |
| 2014 Q2 | 11.8 Million EUR | -51.84% |
| 2014 Q1 | 24.5 Million EUR | -3.92% |
| 2013 Q3 | 46.2 Million EUR | -75.2% |
| 2013 Q1 | 1.8 Million EUR | -93.71% |
| 2013 Q2 | 186.3 Million EUR | 10250.0% |
| 2013 FY | 104.4 Million EUR | -9.38% |
| 2013 Q4 | 25.5 Million EUR | -44.81% |
| 2012 FY | 115.2 Million EUR | 129.03% |
| 2012 Q4 | 28.6 Million EUR | -40.29% |
| 2012 Q3 | 47.9 Million EUR | 351.89% |
| 2012 Q2 | 10.6 Million EUR | -60.0% |
| 2012 Q1 | 26.5 Million EUR | -15.87% |
| 2011 Q3 | 49.3 Million EUR | 825.0% |
| 2011 Q4 | 31.5 Million EUR | -36.11% |
| 2011 Q2 | -6.8 Million EUR | -361.54% |
| 2011 FY | 50.3 Million EUR | -51.59% |
| 2011 Q1 | 2.6 Million EUR | 111.98% |
| 2010 FY | 103.9 Million EUR | -20.93% |
| 2010 Q1 | -3.5 Million EUR | -104.55% |
| 2010 Q2 | 1.5 Million EUR | 142.86% |
| 2010 Q3 | 29 Million EUR | 1833.33% |
| 2010 Q4 | -21.7 Million EUR | -174.83% |
| 2009 Q2 | 58.2 Million EUR | 0.0% |
| 2009 FY | 131.4 Million EUR | -18.08% |
| 2009 Q4 | 76.9 Million EUR | 165.17% |
| 2009 Q3 | 29 Million EUR | -50.17% |
| 2008 FY | 160.4 Million EUR | 50.19% |
| 2007 FY | 106.8 Million EUR | -65.89% |
| 2006 FY | 313.1 Million EUR | 238.85% |
| 2005 FY | 92.4 Million EUR | 28.69% |
| 2004 FY | 71.8 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Clariane SE | 163.18 Million EUR | -12.881% |
| LNA Santé SA | 62.98 Million EUR | -192.469% |